Abstract
Age-related maculopathy (ARM) is the leading cause of visual loss among elderly people in Western countries1. Of all cases of severe visual loss due to ARM, the vast majority are caused by exudative/neovascular complications2. The Macular Photocoagulation Study Group (MPS) demonstrated that laser photocoagulation reduced or delayed severe visual loss in eyes with classic choroidal neovascularization secondary to ARM3. However, only a minority of the patients with exudative lesions are eligible for laser photocoagulation therapy4, and recurrences are common5.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Leibowitz, H.M., Kreuger, E., Maunder, L.R. The Framingham Eye Study Monograph. Sury Ophthalmol. 1980; 24: 335–607.
Ferris, F.L. III, Fine, S.L., Hymen, L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984; 102: 1640–1642.
Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Arch Ophthalmol. 1991; 109: 1109–1114.
Moisseiev, J., Alhalel, A., Masuri, R., Treister, G. The impact of the Macular Photocoagulation Study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol. 1995; 113: 185–189.
Macular Photocoagulation Study Group. Recurrent choroidal neovascularisation after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol. 1986; 104: 503–512.
Bressler, S.B., Maguire, M.G., Bressler, N.M., Fine, S.L. Macular Photocoagulation Study Group. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol. 1990; 108: 1442–1447.
Holz, F.G., Wolfensberger, T.J., Piguet, B. et al. Bilateral macular drusen in age-related macular degeneration. Ophthalmology. 1994; 101: 1522–1528.
Siegelman, J. Foveal drusen resorption one year after perifoveal laser photocoagulation. Ophthalmology. 1991; 98: 1379–1383.
Wetzig, P.C. Photocoagulation of drusen-related macular degeneration: a long-term outcome. Trans Am Ophthalmol Soc. 1994; 92: 299–306.
Figueroa, M.S., Regueras, A., Bertrand, J. Laser photocoagulation to treat soft drusen in age-related macular degeneration. Retina. 1994; 14: 391–396.
Frennesson, I.C., Nilsson, S.E.G. Effects of argon (green) laser treatment of soft drusen in early age-related maculopathy: a 6-month prospective study. Br J Ophthalmol. 1995; 79: 905–909.
Frennesson, I.C., Nilsson, S.E.G. Laser photocoagulation of soft drusen in early age-related maculopathy (ARM). The one-year results of a prospective, randomised trial. Eur J Ophthalmol. 1996; 6: 307–314
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Frennesson, C., Nilsson, S.E.G. (1998). The one-year result of a prospective, randomized study of laser photocoagulation of eyes with soft drusen in early age-related maculopathy. In: Coscas, G., Piccolino, F.C. (eds) Retinal Pigment Epithelium and Macular Diseases. Documenta Ophthalmologica Proceedings Series, vol 62. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5137-5_54
Download citation
DOI: https://doi.org/10.1007/978-94-011-5137-5_54
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-6160-5
Online ISBN: 978-94-011-5137-5
eBook Packages: Springer Book Archive